Showing results (21-30 of 625) with videos related to
Sort By:
Pageof 63
Future Oncology (London, England)|December 23, 2020
Managing recurrent ovarian cancer in daily clinical practice: case studies and evidence review with a focus on the use of trabectedinDomenica Lorusso, Antonio González-Martín, Isabelle Ray-CoquardLa Revue Du Praticien|July 18, 2008
[Adjuvant therapies: the example of breast cancer]Thomas Bachelot, Jean-Paul Guastalla, Isabelle Ray-CoquardPathology|January 1, 2014
The clinician's perspective on sarcoma pathology reporting: impact on treatment decisions?Jean-Yves Blay, Olfa Derbel, Isabelle Ray-CoquardAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Do our current clinical trial designs help to guide clinical practice?Jean-Yves Blay, Olfa Derbel, Isabelle Ray-CoquardCurrent Opinion in Oncology|June 17, 2020
Cabozantinib as an emerging treatment for sarcomaPatrick Schöffski, Jean-Yves Blay, Isabelle Ray-CoquardCancers|April 23, 2022
Molecular Mechanisms of Kaposi Sarcoma DevelopmentAndy Karabajakian, Isabelle Ray-Coquard, Jean-Yves BlayOncology|January 20, 2022
Retacrit®, Biosimilar of Epoetin Alfa, in Chemotherapy-Induced Anemia in Routine Practice: Impact of Iron SupplementationKamel Laribi, Dominique Spaeth, Florian Scotte, et al.BMC Health Services Research|January 15, 2022
What underlies the observed hospital volume-outcome relationship?Marius Huguet, Xavier Joutard, Isabelle Ray-Coquard, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 29, 2020
Rare ovarian tumors: an update on diagnosis and treatmentCharlotte Debuquoy, Clemence Romeo, Helene Vanacker, et al.Current Opinion in Obstetrics & Gynecology|November 28, 2022
Update on new treatments for rare ovarian tumoursStanislas Quesada, Marta Bini, Coriolan Lebreton, et al.Pageof 63